NCT01459614View on ClinicalTrials.gov

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Pancreatic Cancer
Interventions
DRUG

Gemcitabine

IV on Days 4 and 11

DRUG

Taxotere

IV on Days 4 and 11

DRUG

Xeloda

orally, twice a day Days 1-14

DRUG

Cisplatin

IV Days 4 and 11

Trial Locations (1)

21205

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

Swim Across America

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT01459614 - Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter